<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="3" ids="50249">Anticoagulant</z:chebi> activity is present in non-immunoglobulin (IgG) fractions from plasma of patients with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="1" pm="."><plain>Plasma from six patients with primary or secondary APS was passed through a protein A <z:chebi fb="0" ids="2511">sepharose</z:chebi> 4B column </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="3" ids="50249">Anticoagulant</z:chebi> activity in IgG samples and non-IgG samples was determined by both dilute aPTT based clotting assay and by dilute PT based clotting assay </plain></SENT>
<SENT sid="3" pm="."><plain>Thrombin generation was determined by prothrombinase complex assay in the presence of IgG sample or non-IgG sample </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="3" ids="50249">Anticoagulant</z:chebi> activity was detected in the IgG samples with the dilute aPTT based clotting assay and in non-IgG samples with the dilute PT based clotting assay </plain></SENT>
<SENT sid="5" pm="."><plain>The activity was not detected in IgG samples with the dilute PT clotting assay </plain></SENT>
<SENT sid="6" pm="."><plain>Forty percent of total thrombin generation was inhibited in the presence of non-IgG samples although thrombin generation was not inhibited in the presence of IgG samples and beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I </plain></SENT>
<SENT sid="7" pm="."><plain>The <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> activity detected by dilute PT based clotting assay and prothrombinase complex assay was non-IgG, <z:chebi fb="0" ids="16247">phospholipid</z:chebi>-<z:chebi fb="1" ids="39099">Ca+</z:chebi>+-dependent and beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I-independent </plain></SENT>
<SENT sid="8" pm="."><plain>The role of non-IgG <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> should be determined as well as the role of LA Igs antibodies in the mechanisms of <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
</text></document>